22/03/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

22/03/2025

Mar 22, 2025, 10:21 | Blog
Sibylle Loibl: Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases
Sibylle Loibl, Chief Executive Officer of GBG Forschungs GmbH, shared a post on LinkedIn: "New publication…
Mar 22, 2025, 10:19 | Blog
Dégi László Csaba: Proud to be one of the 9 European experts for the CCI4EU Project's 'Deep Dive' into Precision Cancer Medicine
Dégi László Csaba, President of the European Cancer Organisation, shared a post by Portuguese Oncology…
Mar 22, 2025, 10:10 | Blog
Corinne Leach: Innovation in Action at the CancerX Accelerator Moffitt Innovation Summit
Corinne Leach, Director, Digital Ventures and CancerX at Moffitt Cancer Center, shared a post on…
Mar 22, 2025, 09:58 | Blog
One story can change medical practice - EGFR Positive Lung Cancer UK
EGFR Positive Lung Cancer UK shared a post on X: "One story can change medical…
Mar 22, 2025, 09:11 | Science
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 22, 2025, 09:00 | Blog
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Andrea Anampa-Guzmán, Medical student at National University of San Marcos, shared a post on X:…
Mar 22, 2025, 08:43 | Blog
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Richard Sassun, Colorectal Surgery Fellow at Mayo Clinic Rochester, reshared a post by JAMA Surgery on…
Mar 22, 2025, 08:34 | Blog
Registration open for the 8th "Combinations and Sequences in therapy" conference
3P Solution shared a post on LinkedIn: "REGISTRATION OPEN 8th edition of the conference "COMBINATIONS…
Mar 22, 2025, 08:02 | Blog
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
AstraZeneca shared a post LinkedIn: "Today we announced plans to establish a new global strategic…
Mar 22, 2025, 07:56 | Science
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
The Babak Lab shared an article by Meng Rui Chang, et al. on LinkedIn: "Read…
All: 55 Posts: 21 - 30
Special Coverage